Skip to main content

Table 1 The main clinicopathologic parameters of included women (N = 378)

From: Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

 

N (%)

Age, average, range a

55 (30–76)

Menopause b

 Pre-M

198/378 (52%)

 Post-M

180/378 (48%)

Epithelial ovarian cancer c

 Histological subtype

  Serous carcinoma

73/126 (58%)

  Endometrioid carcinoma

30/126 (24%)

  Clear cell carcinoma

16/126 (13%)

  Mucinous carcinoma

7/126 (5%)

FIGO stage

 I

21/126 (17%)

 II

15/126 (12%)

 III

82/126 (65%)

 IV

8/126 (6%)

Tumor grade

 G1

46/126 (37%)

 G3

80/126 (63%)

Lymph node metastasis d

 Yes

50/112 (45%)

 No

62/112 (55%)

Distant metastasis

 Yes

56/126 (44%)

 No

70/126 (56%)

Benign ovarian cyst e

 Endometriosis

81/126 (64%)

 Serous cystadenoma

17/126 (14%)

 Mucinous cystadenoma

20/126 (16%)

 Mature teratoma

8/126 (6%)

  1. Notes: a Average age for 378 age-matched included women
  2. bMenopause status for 378 menopause-matched included women
  3. cThe clinicopathologic parameters of patients with epithelial ovarian cancer (n = 126)
  4. dThe information of lymph node metastasis was only available in 112 EOC patients
  5. eHistological subtype of patients with benign ovarian cyst (n = 126)
  6. Abbreviations: N number, M menopause, FIGO International Federation of Gynecology and Obstetrics, G grade
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us